Gaxos.AI Inc.GXAI

Gaxos Labs markets itself as a developer of AI applications spanning trending sectors, with products like Art-Gen.ai, unGPT.ai, and Bible.ai on the front page of its website. The company’s own filings, however, tell a different story: for the quarter ended 31 March 2026 it generated just $1.8 million in revenue, of which $563,458 came from subscriptions and $23,732 from its trio of named applications. Even the $1.8 million figure looks modest when set against a quarterly operating cash burn of $2.5 million and a net loss of $2.2 million. The contrast between the product pitch and the financial reality is stark enough to make a spreadsheet weep.

The company’s website and team pages showcase a stable of AI tools aimed at creators, developers, and curious minds, positioning Gaxos as a nimble innovator in the crowded AI environment. Yet the 10-Q filing for the quarter to 31 March 2026 shows the bulk of revenue-$1,245,909-came from a single customer, RNK Health, for non-clinical services, a concentration risk that could evaporate tomorrow without a diversified customer base. That single-client dependency is the digital equivalent of building a castle on a sandbar: impressive from a distance, perilous up close.

Filings confirm a cash and cash equivalents balance of $1.5 million at 31 March 2026, set against current liabilities of $569,308 and a working capital position that is, charitably, tight. Operating cash flow for the quarter was $-2.5 million, while research and development expense clocked in at $446,422. The company’s diluted weighted average shares outstanding stood at 8.6 million, and diluted loss per share came in at $-0.25. In short, the story on the ground is one of a cash-burning micro-cap with a single big customer, a small product line, and a balance sheet that is more “lean” than “loaded.”

For context on the company’s governance posture, the latest DEF 14A notes that the board has adopted written charters for the audit, compensation, and (to-be-adopted) nominating and corporate governance committees, all posted on the corporate website. These governance artefacts are commendable, but they do not fund servers, salaries, or server bills. The filing trail also confirms that the company’s product narrative is confined to its website and team pages, with no independent revenue, usage, or adoption metrics disclosed in the filings. The gap between polished platform language and parseable financial evidence remains as wide as a data centre cooling fan set to “max.”

There is no visible chart rail in the evidence pack, and no external market-data source is supplied to back price or volume moves. The company’s SEC filings are the primary source of truth for revenue, cash, and earnings, and those filings show a business that is small, single-customer dependent, and burning cash at a rate that would make a VC blush. Until filings, product usage dashboards, or customer diversification emerge, the operating reality is the only reliable guide.